| Active substance | Cabergoline |
|---|---|
| Active Half-Life | 63-68 hours |
| Classification | Prolactin inhibitor |
| Dosage | 1-2 mg/week |
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | Prolactin levels, liver function tests |
| Also known as | Cabaser |
| WAREHOUSE | International Warehouse 2 |
| Blood pressure | May cause hypotension |
| Trade name | Dostinex |
| Storage conditions | Store at room temperature, protect from light and moisture |
| Chemical name | Cabergoline |
| Formula | C26H37N5O2 |
| Substance class | Ergoline derivative, Dopamine D2 receptor agonist |
| Main action | Inhibition of prolactin secretion |
| Half-life | 63 to 69 hours |
| Dosage (medical) | Typically 0.5 mg per week, may vary based on condition |
| Dosage (sports) | Not specified or recommended for sports use |
| Effects | Reduces prolactin levels, may help treat symptoms associated with hyperprolactinemia |
| Side effects | Nausea, headache, dizziness, orthostatic hypotension |
| Use in sports | Not officially sanctioned, possibly used to control side effects of anabolic steroids |
| Manufacturer | Pfizer |
Reviews
There are no reviews yet.